NCT01762813Recruiting
Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
Prospective, Population-based Cohort Collection of Blood Samples and Tumor Tissue From Patients Operated on for Primary or Metastatic Colorectal Cancer
Source: ClinicalTrials.gov · Last updated 30 Apr 2026
Brief summary (registry, in English)
* A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer * Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colon
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1200 (estimated)
- First submitted
- 3 Jan 2013
- Start date
- 1 Jan 2013
- Primary completion date
- 31 Dec 2035
- Lead sponsor
- Helse Stavanger HF
- Diseases
- Colorectal cancer
- NCT number
- NCT01762813
What you commit to
- Study type: Observational
- Planned participants: 1200
- From 1 Jan 2013 to the primary completion date, 31 Dec 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- failure to provide written informed consent
Who the study is looking for
- Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatment intention of planned curative surgery
- Informed consent to participate
- Age ≥18
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stavanger University Hospital Coordinator of this site? Confirm its status | Stavanger | Norway | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.